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Clinical value and cost of a respiratory sleep-related 
breathing disorders screening service for snorers 
referred to a District General Hospital ENT 
department 
S. J. LLOYD-OWEN, A. CRAWFORD, M. R. PARTRIDGE AND C. M. ROBERTS 
Chest Clinic, Whipps Cross Hospital, Leytonstone, London, U.K. 
Sleep-related breathing disorders and snoring often co-exist in the community. We hypothesized that a significant 
proportion of patients referred from primary care to ENT surgeons for management of snoring might have 
significant sleep-related breathing disorders requiring medical management. The Respiratory Medicine Department 
at Whipps Cross Hospital, London, U.K. screened all such referrals using sleep questionnaires, overnight oximetry 
and diagnostic sleep studies where necessary as recommended by the Royal College of Physicians of London. Over 
38 months, 115 patients were screened, of whom 43 (38%) had clinically significant sleep-disordered breathing. 
One-third were established on nasal continuous positive airway pressure ventilation and the remainder were mainly 
offered conservative treatment. The cost of the screening service is estimated at &14 000 for the initial year. The 
savings to the ENT service and the possible long-term benefits to the patients identified as having sleep-disordered 
breathing balance this. We conclude that screening all referred snorers for sleep-disordered breathing using a simple 
protocol identifies a significant number requiring medical management at a relatively low cost to the service 
provider. 
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Introduction 
Sleep-related breathing disorders (SBD), predominantly 
apnoealhypopnoea syndrome, are common disorders with 
population studies revealing the prevalence amongst 
middle-aged men as between 0.89 (1) and 9.9% (2), depend- 
ing upon the definitions used. Amongst middle-aged 
women, the prevalence has been estimated at 2% (3). The 
presence of sleep-disordered breathing has been shown to 
be commoner in snorers than non-snorers (4), including 
those who self-report snoring (5). 
Whilst SBD is an important cause of excess morbidity 
and probably mortality, this has not been shown to be the 
case for simple snoring alone. Case-controlled studies 
clearly describe an increase in morbidity from road traffic 
accidents in those with sleep apnoea (6). Several studies 
have shown associations with reduced life expectancy (7) 
comprising acute cardiovascular events (8,9) and stroke 
(10). 
Knowledge of the symptoms and signs of SBD in the 
community remains poor. Even amongst medical prac- 
titioners, there is a wide variance of knowledge (11). Many 
patients who seek advice from their general practitioners 
about their snoring are initially referred to ENT surgeons. 
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Within the ENT profession, there is a growing consensus 
that all heavy snorers should been screened for SBD prior 
to surgery and that treating snoring alone will not reduce 
the morbidity of SBD (12). One of the most commonly 
used surgical therapies for snoring, uvuolpalatopharyngo- 
plasty (UPPP), has been evaluated extensively with variable 
outcomes (13). Snoring may be abolished, but apnoeas 
often continue (14,15). Perioperative and immediate post- 
operative complications are not uncommon in those with 
undiagnosed sleep-disordered breathing and deaths have 
been recorded (16). Later complications are also common, 
occurring in over one-third in one study (15). There 
are suggestions that benefits from UPPP decrease with 
time (17). 
In contrast, the most successful treatment for sleep 
apnoea associated with daytime somnolence is nasal con- 
tinuous positive airway pressure ventilation (NCPAP) 
which, in a District General Hospital (DGH), is usually 
administered by the Respiratory Medicine Department and 
not the ENT service. Importantly, there is less success in 
establishing NCPAP if the patient has had previous UPPP. 
NCPAP is efficacious in relieving upper airway obstruction, 
normalizing respiration during sleep (18). There is evidence 
that it reduces sleepiness and improves cognitive perform- 
ance (19) and increases survival when compared to 
treatment with UPPP (20). Recent Royal College of 
Physicians of London guidelines have recommended the 
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establishment of sleep disorders screening services in all 
District General Hospitals based upon a somnolence ques- 
tionnaire and basic overnight sleep studies (21). We estab- 
lished such a one-stop screening clinic for all ENT referrals 
with a primary diagnosis of snoring. This study aimed to 
determine the value of such an approach by identifying the 
proportion of such patients with clinically significant SBD 
requiring non-surgical treatment and estimating the cost of 
such a screening service. 
Methods 
SCREENING CLINIC 
Referral letters sent to the ENT service with a primary 
diagnosis of snoring and request for management advice 
were deflected to the Chest Clinic outpatient appointment 
staff who followed a simple screening protocol. An explana- 
tory letter from the Chest Clinic enclosing a Sleep Ques- 
tionnaire (Appendix 1) was then sent out to the patients. 
Arrangements were made by a Respiratory Nurse Specialist 
(A.C.) for them to have home overnight oximetry measured 
(Minolta Pulsox7, Sunrise Medical, Heston, U.K.) and an 
appomtment in the Chest Clinic with a Consultant in 
Thoracic Medicine (C.M.R., M.R.P.). The oximetry traces 
were analysed and a preliminary diagnosis of SBD typical 
of sleep apnoealhypopnoea syndrome was made on the 
basis of characteristic desaturations of more than 4% from 
a baseline above 90% at least 10 times per hour for at least 
one hour. Traces showing no desaturations were classed as 
normal. Those with other desaturations not fulfilling the 
criteria of SBD typical of sleep apnoealhypopnoea syn- 
drome were considered separately. The questionnaire 
results, together with the history taken at the consultation, 
were then used to divide the patients into those with and 
without symptoms suggestive of SBD. Hypersomnolence 
was accepted if the patient reported at least one of wit- 
nessed apnoeas, unplanned naps and lack of feeling 
refreshed in the morning. Those with normal traces, but 
with symptoms of hypersomnolence, underwent inpatient 
sleep studies in this hospital (Densa D1500, Densa Ltd, 
Flint, Wales, U.K.). Those with desaturations not typical 
of SBD also had sleep studies requested, regardless of 
symptoms. 
The inpatient sleep study recorded nasal and mouth 
airflow, abdominal and chest wall movement giving a 
paradoxical movement index, leg movement, pulse, body 
position and audible snoring in addition to heart rate and 
pulse oximetry. 
Treatment for those found to have SBD was individual- 
ized depending on the degree of symptoms, the factors 
involved e.g. body mass index and the patient’s wishes. All 
patients were given advice on conservative measures includ- 
ing diet, sleeping posture, alcohol and sedative avoidance 
where appropriate. Additional measures offered to selected 
patients included NCPAP in those with significant daytime 
somnolence, and assessment by an ENT surgeon when 
snoring with predominant nasal symptoms was reported. 
Those without evidence of SBD were also re-referred to the 
ENT service for further assessment and treatment of their 
simple snoring. 
EVALUATION 
A retrospective analysis was made on completion of 38 
months of the screening service. The prevalence of clinically 
significant SBD amongst the referred snorers was estimated 
using data from both oximetry and full inpatient sleep 
studies combined with questionnaire responses indicating 
daytime somnolence. The treatment options offered to this 
group were then recorded. Finally the financial and service 
implications to the Respiratory Service of offering this 
screening clinic were considered, based on contract pricing 
used at that time by the Forest Healthcare NHS Trust 
responsible for the service. 
STATISTICAL ANALYSIS 
The Student’s t-test and the chi-square test were applied 
followed by odds ratios to evaluate significant associations 
with SBD of the variables gender, age, body mass index, 
collar size, alcohol use and smoking. 
Results 
REFERRALS 
Between March 1993 and June 1996, 132 outpatient refer- 
rals were redirected from the ENT service to the Chest 
Clinic. 
Seventeen patients (13%) did not respond to the subse- 
quent Chest Clinic correspondence. All others returned 
completed questionnaires and underwent home overnight 
oximetry. No patients who underwent oximetry failed to 
arrive at the Chest Clinic appointment. One hundred and 
fifteen were therefore screened; 89 men and 26 women. The 
mean age was 45 years with a mean body mass index of 
29.4 kg m -‘. The mean collar size was 41.7 cm and 34% of 
the patients were smokers. 
OVERNIGHT OXIMETRY 
Oximetry was carried out in all of the patients. In only one 
case was data collected not interpretable due to repeated 
patient difficulties in managing the equipment. The traces 
were analysed and three categories defined: 69 (60%) had 
normal traces; 33 (29%) met the desaturation criteria for 
SBD typical of sleep apnoealhypopnoea; and 12 (10%) had 
other desaturation patterns. Examples are shown in Fig. 1. 
The relationship between diagnostic category defined by 
oximetry and presence of hypersomnolence is given in 
Table 1. A small minority of those categorized as having 
normal traces had symptoms. 
SLEEP STUDIES 
Sleep studies were requested on 17 patients: those with 
normal traces and symptoms, those with desaturations 
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FIG. 1. Examples of overnight oximetry traces. 1, Normal; 2, desaturations typical of sleep apnoea/hypopnoea type of 
sleep-related breathing disorders (SBD); 3, desaturations from SBD not typical of sleep apnoeas and usually found to be 
hypoventilation syndrome. 
requiring further analysis and one other (the patient with 
technical difficulties who did have symptoms). Sleep studies 
were denied to two patients by the purchasing authorities. 
Sleep studies were therefore carried out on 15 patients 
(13%). 
After the sleep studies, of the four patients with symp- 
toms of hypersomnolence and normal overnight oximetry, 
three were found to have SBD. Of the 10 people studied 
who had desaturations requiring further analysis, six had 
SBD, five of which were typical of sleep apnoea syndrome. 
The one patient in whom oximetry was technically difficult 
was also shown to have SBD suggestive of sleep apnoea on 
the inpatient study. 
TABLE 1. Relationship between the category defined by 
oximetry and the presence of hypersomnolent symptoms on 
the questionnaire 
Category from oximetry SBD Normal 
Hypersomnolent symptoms 28 4 
No hypersomnolent symptoms 17 65 
Total 45 69 
SBD: Sleep-related breathing disorders (one patient 
excluded in whom oximetry not completed). 
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TABLE 2. Characteristics of patients with a diagnosis of sleep disordered breathing or snoring alone. 
One 6-year old patient and the two in whom sleep studies were denied are excluded 
SBD 
(72=43) 
Snorers only 
(n=69) P-value 
Male:female (%) 85:15 72:28 
Age (years), mean (range) 48 (30-72) 45 (24-79) 
Collar size (cm), mean 43.4 40.9 
Body mass index (kg m- ‘), mean 31.4 28.2 
Smokers (%) 40 25 
Alcohol (units week- ‘), mean 8.1 7.9 
Very heavy snorers (%) 88 74 
Witnessed apnoeas (%) 83 45 
Don’t wake refreshed (%) 79 81 
Planned daytime nap (%) 0 6 
Unplanned daytime nap (%) 78 43 i 
SBD: Sleep-related breathing disorders. 
*Chi-square test; TStudent’s t-test with 108 degrees of freedom; IQuestionnaire percentages not 
statistically analysed as used to define presence of SBD. 
TABLE 3. Estimate of purchasers’ costs to set up respiratory lead screening of snorers referred to ENT 
service and NCPAP therapy for those requiring therapy for sleep-related breathing disorders 
Service 
Number 
per year 
cost 
per patient 
cost 
per year 
Initial assessment 36 219.5 57020 
Sleep studies 6 &220 cl320 
NCPAP therapy - first year 5 El160 55800 
Total for first year &14 140 
NCPAP therapy - subsequent years Add 5 2250 Add 51500 each year 
Based on 1996 prices used by Forest Healthcare NHS Trust. 
NCPAP: nasal continuous positive airway pressure ventilation. 
SLEEP-DISORDERED BREATHING 
SBD was diagnosed in 43 patients (38%). Of patients 
screened, 40% of men and 24% of women had SBD. Of 
these, 41 had SBD typical of sleep apnoea, while the 
remaining two had other patterns of sleep-related hypo- 
ventilation. The characteristics of the patients with and 
without SBD are summarized in Table 2. Those patients 
with SBD had statistically significant larger collar sizes and 
body mass indices. 
TREATMENT An estimation of the yearly costs of the service at 1996 
prices is detailed in Table 3. 
Of the 43 with oximetry and somnolence typical of sleep- The total costs for the initial year are estimated at 
related breathing disorders or diagnostic sleep studies, &14 140 with costs escalating at a rate of &lSOO per year, 
all were given advice regarding conservative measures assuming that no patients on NCPAP stop their therapy or 
detailed above. Nineteen (44%) with socially disruptive die. The initial set up costs include &2500 for the Oximeter 
somnolence had a NCPAP trial, of which 14 continued with and printer plus &8500 for the Densa inpatient Sleep Study 
it successfully. Of the 24 not given NCPAP, none had 
severe hypersomnolence: nine responded to diet and other 
conservative measures, eight were thought to have a con- 
tributing ENT condition and were reassessed by the ENT 
service and seven did not attend for further follow-up. The 
snorers without evidence of SBD were all given conserva- 
tive advice and usually re-referred to the ENT service for 
further evaluation. 
COST ANALYSIS 
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device (1996 prices). To offset these, approximately 40 ENT 
consultations, priced at &61 each, were avoided (total 
&2440). The price of ENT surgical procedures at that time 
ranged from a day-case nasal septoplasty at &211 to a 
UPPP at &2863. Polysomography at the most local tertiary 
referral centre costs a minimum of &570 (pers commun. 
from the London Chest Hospital). 
Discussion 
In this study, 38% of apparent snorers referred to the ENT 
service were identified as having clinically significant sleep- 
related breathing disorders (SBD) when screened. As a 
result the majority received either NCPAP or conservative 
advice and was mostly directed away from ENT clinics for 
consideration of surgical and other interventions. 
The high prevalence of SBD in our referral group is 
similar to that found in other studies of patients referred to 
Sleep Clinics. Ryan et al., in the U.K., screened patients 
using both oximetry and polysomnography in all patients 
and confirmed SBD in 32 out of 69 patients (46%) (22). A 
similarly studied population of 240 snoring patients in 
Canada also had a SBD prevalence of 46% (23). In a 
random sample of over 600 men in Belgium, 18% of those 
who mostly complained of habitual snoring were found to 
have SBD on polysomography (24). 
We also found that patients diagnosed as having SBD 
after referral for snoring were more likely to be male, older 
and current smokers. Statistically significant associations 
were found between SBD and larger collar sizes and 
with body mass indices. This matches previously reported 
associations with SBD (23,24). 
Our study may be criticized for underdiagnosing SBD in 
our referral groups because full polysomnography was not 
used. However, this study is aimed at identifying the 
resource implications in a DGH for screening of snorers 
and we have taken a pragmatic view of the definition of 
clinically significant SBD. This approach is recommended 
by the Royal College of Physicians of London (21) and 
supported by Wright and colleagues in their recent 
evidence-based review of the treatment of sleep apnoea 
(25). 
Witnessed apnoeas and unplanned naps have been vali- 
dated as the best predictors of SBD out of all the questions 
usually asked in a Sleep Questionnaire (26). Whilst some 
subjects with mild SBD and no symptoms may be missed 
using this system, the relevance of this to clinical practice is 
not known to be significant (25). Treatment with NCPAP 
is usually only indicated in those with serious daytime 
somnolence. 
Patients accepted the screening system used with only a 
small minority failing to return questionnaires and booking 
oximetry. All patients who returned questionnaires 
attended for oximetry and subsequent outpatient visits, 
giving a 0% failed-to-attend rate. Only one subject was 
unable to follow the simple instructions to activate the 
oximeter. When seen by the consultant as an outpatient, 
most subjects will already have provided sufficient informa- 
tion to allow a one-stop consultation. This suggests that the 
process is simple, well tolerated and efficient in use o 
patient and doctor time. 
The resource implications of a SBD screening service fo 
all ENT referrals deserve major consideration. Firstly, fo 
the Respiratory Medicine service, the number of nev 
patient referrals with snoring would occupy approximatel! 
one in 12 of all new patient clinic slots for one consultant i: 
our referral pattern is maintained. However, the use of s 
prepared questionnaire and oximetry trace performed 
before the initial consultation reduces the need for 
follow-up with only one-third of patients requiring more 
than one appointment, always for continuing care of SBD. 
This workload, however, is likely to build with time due to 
increasing responsibility for the continuing care of NCPAP 
users. There are alternative strategies for handling this 
caseload, for example by using nurse practitioner clinics to 
deliver continuing care. 
The cost to the purchaser of the initial screening process 
is relatively inexpensive with an estimated cost at our 
institution of &195 per subject. The total cost to the 
purchasers of the screening service for snorers is estimated 
at 214 000 for the initial year? including care for those 
requiring NCPAP. This workload and the costs have to be 
balanced against the savings to the ENT service, with over 
one-third of patients referred to them with snoring diag- 
nosed as having SBD. Whilst it is generally accepted that 
surgery is not the preferred treatment for SBD, it is not 
usually possible to differentiate this from simple snoring on 
clinical grounds alone in most patients. Before the institu- 
tion of the screening service, ENT surgeons were left with 
the choice of an expensive tertiary referral for polysomnog- 
raphy or reliance on fallible clinical grounds. It is not 
possible to provide an accurate prediction of the number 
and type of surgical treatments that might have been 
recommended for the snoring patients in the absence of the 
diagnosis of SBD. Nevertheless, if three UPPP procedures 
were carried out per year, the costs of the total ENT 
commitment would equal the cost of this comprehensive 
screening service. More significantly perhaps, the reduced 
future morbidity of these patients from medical or acciden- 
tal complications of their undiagnosed and untreated SBD 
should have resource and financial implications for the 
future. 
Many ENT services already offer a screening program 
for snorers to exclude sleep-disordered breathing before 
considering surgical intervention and several teaching cen- 
tres have facilities for full polysomography and even nasal 
endoscopy during sleep. However, in most DGHs the 
service is not available. Co-operation between ENT and 
respiratory services such as we have demonstrated is often 
the most practical and cheapest option as the Respiratory 
Department usually has experience in and/or facilities for 
the diagnosis and management of SBD. 
We have tested the Royal College of Physicians of 
London’s recommendation for DGH screening for SBD 
(21). Our experience suggests that the recommended system 
is inexpensive, efficient in time use of patient and doctor 
and has a significant impact on the diagnosis and manage- 
ment of patients referred for the assessment and treatment 
of snoring. 
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Appendix 1 
SLEEP QUESTIONNAIRE 
PLEASE CIRCLE THE CORRECT ANSWER FOR YOU 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
How loudly do you snore? 
Has anyone ever noticed you have stopped breathing whilst asleep? 
If Yes, was this during deep sleep or at the beginning of sleep? 
Do you ever awake from sleep feeling choked? 
Do you wake in the night most nights to pass water? 
Do you wake in the morning feeling refreshed? 
Do you have a planned nap most days of the week? 
Do you fall asleep in front of the TV or whilst reading the paper 
most days of the week? 
What is your collar size? 
What was your collar size 5 years ago? 
What is your weight? 
What was your weight 5 years ago? 
What is your height? 
How much alcohol do you drink on average in a week? 
How many cigarettes do you smoke each day? 
Not very loudly/loudly/very loudly 
Yes/No 
Yes/No 
Yes/No 
Yes/No 
Yes/No 
Yes/No 
